Is 18F-flutemetamol PET/CT able to reveal cardiac amyloidosis?

Details

Serval ID
serval:BIB_A98AC09F5BDF
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Title
Is 18F-flutemetamol PET/CT able to reveal cardiac amyloidosis?
Journal
Clinical Nuclear Medicine
Author(s)
Lhommel R., Sempoux C., Ivanoiu A., Michaux L., Gerber B.
ISSN
1536-0229 (Electronic)
ISSN-L
0363-9762
Publication state
Published
Issued date
2014
Peer-reviewed
Oui
Volume
39
Number
8
Pages
747-749
Language
english
Notes
Publication types: Journal Article Publication Status: ppublish
Abstract
We report here the case of a 56-year-old man with well-documented cardiac light chain amyloidosis successfully imaged with F-flutemetamol PET/CT in 2011. A matched pair healthy volunteer was imaged in the same conditions, and no specific heart uptake could be detected. The present report suggests the potential benefit of this new pharmaceutical in this indication, as it has been recently reported for C-Pittsburgh compound B, but with the main advantage to benefit from the more practical half-life of F. Further prospective trials would, however, be required to define the potential impact of F-flutemetamol PET/CT in cardiac amyloidosis.
Pubmed
Web of science
Create date
16/01/2015 12:11
Last modification date
20/08/2019 15:13
Usage data